본문 바로가기

타이틀 타이틀

  • ABOUT
    • General Information
    • CEO Message
    • Organization
    • History
    • Global Network
    • Recruit
  • PRODUCT
    • Product
    • Trouble shooting
    • COA
    • Inquiry
    • Feedback
  • TECHNOLOGY
    • Platform
    • PIpeline
    • Application
    • Facility
  • KNOWLEDGE CENTRE
    • Trends
    • Publication
  • IR
    • Financial Statement
    • Disclosure
    • Financial Reports
  • PR
    • Notice
    • News
    • Xcell Story
    • Inquiry
  • EN
  • KR
검색
  • EN
  • KR

ABOUT

  • General Information
  • CEO Message
  • Organization
  • History
  • Global Network
  • RECRUIT

PRODUCT

  • Product
  • Trouble shooting
  • COA
  • Inquiry
  • Feedback

TECHNOLOGY

  • Platform
  • PIpeline
  • Application
  • Facility

KNOWLEDGE CENTER

  • Trends
  • Publication

IR

  • Financial Statement
  • Disclosure
  • Financial Reports

PR

  • Notice
  • News
  • Xcell Story
  • Inquiry

IR

  • Financial Statement
  • Disclosure
  • Financial Reports

Financial Reports

notice

주식명의개서정지공고

2022.04.04


 

PREV

외부감사인 변경 선임 공고

NEXT

전자증권 전환 대상 주권 권리자(주주) 보호 및 조치사항 안내

333, Yeongdong-daero, Gangnam-gu, Seoul, Republic of Korea (06188)

  • TEL (+82-2) 863-1331
  • FAX 02-863-0832
  • E-MAIL xcell@xcell.co.kr

© 2020 Xcell Therapeutics Inc., Copyright

  • Privacy Policy